Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000062J1
HKD
474.20
20.6 (4.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
No of Months
12
12
12
12
12
Profit Before Tax
-385.00
-154.00
-516.00
-659.00
-1,072.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-99.00
-521.00
304.00
40.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-119.00
-465.00
65.00
-318.00
-633.00
Cash Flow from Investing Activities
445.00
-891.00
-1,133.00
-37.00
-113.00
Cash Flow from Financing Activities
1,874.00
1,124.00
2,633.00
367.00
828.00
Net Cash Inflow / Outflow
2,144.00
-208.00
1,586.00
12.00
79.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-55.00
24.00
21.00
0.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-385.851724835696
3995.37420944849
-4,380.00
-109.66%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-99.7186703678332
-4736.21868362027
4,637.00
97.89%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-119.536165921048
282.2303152368
-401.00
-142.35%
Cash Flow from Investing Activities
445.754288694189
-4240.4563286626
4,685.00
110.51%
Cash Flow from Financing Activities
1874.12254053431
-109.252383119502
1,983.00
1815.41%
Net Cash Inflow / Outflow
2144.50831565928
-4063.30073047708
6,207.00
152.78%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-55.8323476481715
4.17766606821655
-59.00
-1436.45%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 74.35% vs -814.78% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-119.54
-465.97
74.35%